Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

DARREN SCHMIDT

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1134159692
CMS profile
509443
Location
ALBUQUERQUE, NM

General Payments · PY2019–2023

$1,564.70

  • Reported across 24 records
  • CMS publication 2026-06-30

Latest program year · PY2023

$1,318.47

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $979.63 4
Food and Beverage $263.31 8
Education $75.53 2

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
Bayer HealthCare Pharmaceuticals Inc. $1,224.88 11
Amgen Inc. $72.45 1
Acerta Pharma LLC $18.06 1
Retrophin, Inc. $3.08 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $80.28 2
PY2020 $79.98 4
PY2021 $62.42 3
PY2022 $23.55 1
PY2023 $1,318.47 14

Payment records · PY2023 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2023 2019202020212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $72.45 02/24/2023 Education Undisputed 06/30/2026 1020561445 CMS
AstraZeneca Pharmaceuticals LP $18.06 11/30/2023 Food and Beverage Undisputed 06/30/2026 1015998055 CMS
Bayer Healthcare Pharmaceuticals Inc. $186.10 01/17/2023 Travel and Lodging Undisputed 06/30/2026 1000659039 CMS
Bayer Healthcare Pharmaceuticals Inc. $325.48 01/17/2023 Travel and Lodging Undisputed 06/30/2026 1000660039 CMS
Bayer Healthcare Pharmaceuticals Inc. $2.56 01/18/2023 Food and Beverage Undisputed 06/30/2026 1000544133 CMS
Bayer Healthcare Pharmaceuticals Inc. $2.93 01/18/2023 Food and Beverage Undisputed 06/30/2026 1000544445 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.20 01/18/2023 Food and Beverage Undisputed 06/30/2026 1000597889 CMS
Bayer Healthcare Pharmaceuticals Inc. $33.83 01/18/2023 Food and Beverage Undisputed 06/30/2026 1000646875 CMS
Bayer Healthcare Pharmaceuticals Inc. $33.83 01/18/2023 Food and Beverage Undisputed 06/30/2026 1000646885 CMS
Bayer Healthcare Pharmaceuticals Inc. $64.95 01/18/2023 Food and Beverage Undisputed 06/30/2026 1000649173 CMS
Bayer Healthcare Pharmaceuticals Inc. $87.95 01/18/2023 Food and Beverage Undisputed 06/30/2026 1000650725 CMS
Bayer Healthcare Pharmaceuticals Inc. $186.10 01/18/2023 Travel and Lodging Undisputed 06/30/2026 1000659029 CMS
Bayer Healthcare Pharmaceuticals Inc. $281.95 01/18/2023 Travel and Lodging Undisputed 06/30/2026 1000659749 CMS
Travere Therapeutics, Inc. $3.08 11/14/2023 Education Undisputed 06/30/2026 1059606861 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.